Registration Dossier

Toxicological information

Toxicity to reproduction

Currently viewing:

Administrative data

screening for reproductive / developmental toxicity
based on test type (migrated information)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference Type:
study report

Materials and methods

Test guidelineopen allclose all
according to
OECD Guideline 422 (Combined Repeated Dose Toxicity Study with the Reproduction / Developmental Toxicity Screening Test)
Version / remarks:
adopted March 1996
according to
other: EPA OPPTS 870.3650, adopted July 2000
GLP compliance:
yes (incl. certificate)
Limit test:

Test material

Details on test material:
- Name of test material (as cited in study report): Laromer PO33F
- Physical state: yellowish liquid
- Analytical purity: The test item is a complex mixture of isomers and homologues components. Thus, no purity can be stated (see analytical report No: 11L00272 for details).
- Purity test date: 2011-12-19
- Lot/batch No.: 110007P040
- Expiration date of the lot/batch: 2012-11-30
- Stability under test conditions: confirmed for up to 7 days (see study report No. 11L00387)
- Storage condition of test material: room temperature under light exclusion

Test animals

Details on test animals and environmental conditions:
- Source: Charles River Laboratories, Research Models and Services, Germany GmbH (male and female animals were derived from different litters to rule out mating of siblings)
- Age at study initiation: 10-11 wks
- Weight at study initiation: on average: Males: 335g; Females: 197g
- Fasting period before study: no
- Housing: single (except during mating and during lactation) in Markrolon type M III cages
- Diet (e.g. ad libitum): ground Kliba maintenance diet mouse-rat “GLP”, meal ad lib.
- Water (e.g. ad libitum): ad lib.
- Acclimation period: app. 1 week

- Temperature (°C): 20-24°C
- Humidity (%): 30-70%
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12h/12h

Administration / exposure

Route of administration:
oral: gavage
corn oil
Details on exposure:
PREPARATION OF DOSING SOLUTIONS: The desired amount of test substance was weighed, and corn oil was added up to the correct volume. To prepare a homogenous suspension, the mixture was stirred with a magnetic stirrer also during administration. The test substance preparations were produced at least once a week and were stored at room temperature. The administration volume was 4 mL/kg body weight.

- Justification for use and choice of vehicle (if other than water): The test substance is poorly soluble in water, but forms a homogenous suspension in corn oil, which is also non-toxic to rats.
- Concentration in vehicle: 1.25; 3.75; 12.5g/100mL
Details on mating procedure:
- M/F ratio per cage: 1:1 over night
- Length of cohabitation: until sperm was detected in vaginal smear or for a maximum of 14 days
- Proof of pregnancy: sperm in vaginal smear referred to as day 0 of pregnancy
- After successful mating each pregnant female was caged (how): individually
Analytical verification of doses or concentrations:
Details on analytical verification of doses or concentrations:
Homogeneity and concentration control analyses of the test-substance preparations were performed in all concentrations at the start of the administration period. Additionally, samples from all concentrations as reverse samples for concentration control analysis were taken at the end of the study. The concentration control analyses of all concentrations revealed that the values were in the expected range of the target concentrations, i.e. were always in a range of about 90.0-110.0% of the nominal concentrations. Considering the low relative standard deviation in the homogeneity analysis, it can be concluded that Laromer PO 33 F was distributed homogeneously in corn oil.
Duration of treatment / exposure:
Males: 35 days
Females: 56 days
Frequency of treatment:
daily (except to animals being in labor)
Doses / concentrations
Doses / Concentrations:
50, 150, 500 mg/kg b.w.
actual ingested
No. of animals per sex per dose:
Control animals:
yes, concurrent vehicle
Details on study design:
- Dose selection rationale: The selection of doses was based on the results of a test study in female Wistar rats (BASF project No. 10C0457/11S163) conducted at dose levels of 0, 600 and 1000 mg/kg bw/d. In this study, a NOAEL was not established due to erosions and ulcerations in the stomach of different animals at both dose levels of 600 and 1000 mg/kg bw/d as well as clinical findings like poor general condition, piloerection and body weight loss after 1 week of treatment.
Positive control:


Parental animals: Observations and examinations:
- Time schedule: twice daily on workdays, daily on weekends and public holidays
- Cage side observations: check for moribund animals, pertinent behavioral changes, signs of overt toxicity, parturation, littering and lactation behavior of the dams

- Time schedule: prior to the first administration, weekly thereafter
- The following parameters were examined: abnormal behavior during “handling”, fur, skin, posture, salivation, respiration, activity/arousal level, tremors, convulsions, abnormal movements, impairment of gait, lacrimation, palpebral closure, exophthalmus, feces (appearance/consistency), urine, pupil size

- Time schedule for examinations: day 0, weekly thereafter with the following exceptions for females: During the mating period the parental females were weighed on the day of positive evidence of sperm (GD 0) and on GD 7, 14 and 20. Females with litter were weighed on the day of parturition (PND 0) and on PND 4.

- Food consumption for each animal determined: Yes, except during mating

WATER CONSUMPTION: Monitored by daily visual inspection

OTHER (for details see entry for this study in the repeated dose section):
- Functional observation battery and motor activity measurement of 5 males and females per group 2 days prior to sacrifice
- Urinanalysis in 5 males and females per group one day prior to necropsy
- Clinicochemical and hematological examinations 5 males and females on the day of necropsy after fasting for 16h
Sperm parameters (parental animals):
Parameters examined in male parental animals:
testis weight, epididymis weight, stages of spermatogenesis in the male gonads
Litter observations:
The following parameters were examined in F1 offspring:
number and sex of pups, stillbirths, live births, postnatal mortality, presence of gross anomalies, clinical symptoms, weight gain

yes, externally and organs were assessed macroscopically
Postmortem examinations (parental animals):
- Male animals: All surviving animals on day 36
- Maternal animals: All surviving animals on day 57

- Gross necropsy consisted of external and internal examinations

The following tissues were weighed
- in all animals: epididymides, testes
- in 5 males and females of each group: adrenal glands, brain, heart, kidneys, liver, spleen, thymus
The uteri of all cohabited female parental animals were examined for the presence and number of implantation sites. The uteri of apparently non-pregnant animals or empty uterus horns were placed in 1% ammonium sulfide solutions for about 5 minutes in order to be able to identify early resorptions or implantations.
The following tissues were examined histotechnically in at least 5 animals per sex of the control and high dose group (reproductive organs were examined in all high dose and control animals):
adrenal glands, gross lesions (all affected animals in all dosage groups), bone marrow (femur), brain, cecum, cervix, coagulation glands, colon, duodenum, epididymides, heart, ileum, jejunum, kidneys, liver, lungs, lymph nodes (auxillary and mesenteric), ovaries, oviducts, prostate gland, peyer's patches, rectum, sciatic nerve, seminal vesicles, spinal cord, spleen, stomach, testes, thymus, thyroid glands, trachea, urinary bladder, uterus, vagina
Postmortem examinations (offspring):
- All surviving pubs were subjected to postmortem examinations: external examination and macroscopic examination of organs. Animals with notabel findings or abnormalitites were evaluated on a case-by-case basis.
Reproductive indices:
For the males, mating and fertility indices were calculated for F1 litters according to the following formulas:
Male mating index (%) = number of males with confirmed mating (vaginal sperm detected in females) / number of males placed with females x100
Male fertility index (%) = number of males proving their fertility (implants in utero) / number of males placed with females x100

For the females, mating, fertility and gestation indices were calculated for F1 litters according to the following formulas:
Female mating index (%) = number of females mated (vaginal sperm detected) / number of females placed with males x100
Female fertility index (%) = number of females pregnant (implants in utero) / number of females mated (vaginal sperm or implants in utero) x100
Gestation index (%) = number of females with live pups on the day of birth / number of females pregnant x100
Offspring viability indices:
Live birth index (%) = number of liveborn pups at birth / total number of pups born x100
Viability index (%) = number of live pups on day 4 after birth / number of live pups on the day of birth x100

Results and discussion

Results: P0 (first parental animals)

Details on results (P0)

Female animal No. 131 of test group 3 (500 mg/kg bw/d) was sacrificed in a moribund condition on study day 51 (GD 24). Vaginal discharge was observed on GDs 23-24 in this animal, which showed poor general state and was unable to deliver on GD 24. This animal was sacrificed moribund on the same day. According to the pathological results the findings were assessed as being incidental and not related to treatment.

Almost all male and most female animals of the high dose group showed salivation within 2 hours after the administration on several days of the study. Salivation within 2 hours after treatment was also seen in several mid dose male and female animals. From the temporary, short appearance immediately after dosing it was concluded that salivation was induced by a bad taste of the test substance or local affection of the upper digestive tract.

No test substance-related changes in body weight or body weight gain were observed for all test groups.

For all male and female animals mating was confirmed (mating index of 100%). Male and female fertility index varied between 80% and 90%. All pregnant rats in all dose groups delivered pubs with the exception of 1 high dose female which was sacrificed moribund on GD24.
High dose female animal No. 135, that was not pregnant, revealed a decrease in ovary size and a diffuse atrophy of both ovaries and no corpora lutea. This was regarded to be the cause of the infertility in this pair. All other females and their male mating partners did not show gross lesions in reproduction relevant organs which could explain the lack of offspring.

All mean weight parameters (absolute and relative) did not show significant differences when compared to the control groups.

All gross lesions noted were single observations and they were regarded to have developed spontaneously and unrelated to compound and treatment.

All findings were considered to be incidental or spontaneous in origin and without any relation to treatment.
The high dose female animal No. 131 that was sacrificed in a moribund state revealed a decidual reaction with consequent inflammation of the uterus. Decidual reaction is a proliferation of decidual cells (tissue of endometrial origin lining of the uterus, which is in contact with the fetal membranes and the placental plate). They often are assiocated with inflammation as observed in this animal. The local inflammation in the uterus can lead to disturbance of the general condition or, if the inflammation is spreading, sepsis. This was regarded to be the reason for the moribund state of this animal but was not regarded to be treatment-related.

Effect levels (P0)

open allclose all
Dose descriptor:
systemic toxicity
Effect level:
>= 500 mg/kg bw/day
Based on:
test mat.
Dose descriptor:
fertility and reproductive performance
Effect level:
>= 500 mg/kg bw/day
Based on:
test mat.

Results: F1 generation

Details on results (F1)

Single stillborn pubs were seen in the low dose and mid dose group only. The mean number of delivered pups per dam and the rate of liveborn and stillborn pups reflect the normal range of biological variation inherent in the strain used in this study.
The viability index as indicator for pup mortality between PND 0 and 4 was 89% in the low dose group (all pups of female No. 113 died), 99% in the mid dose group (1 pup of female No. 124 died) and 100% for high dose and control females. As the decreased viability index in the low dose group was still within the historical control data, statistically not significant, and related to mentioned litter loss of only one female animal, the finding was assessed to be incidental and not related to treatment.
The sex distribution and sex ratios of live F1 pups on the day of birth and on PND 4 did not show biologically relevant differences between test groups.

Ten of 14 pups in the litter of low dose female animal No. 113 showed reduced nutritional condition on PND 0. All pups in this litter died between PND 0-1. Each one pup of mid dose female animals Nos. 122 and 124 died on PND 0. These findings were assessed as being incidental as no dose-reponse relationship occurred. The surviving F1 pups of any test group did not show adverse clinical signs up to scheduled sacrifice on PND 4.

Mean pup body weights/pup body weight changes of all pups in all test groups were comparable to the concurrent control values.

No test substance-related changes were observed.

Effect levels (F1)

Dose descriptor:
developmental toxicity
Effect level:
>= 500 mg/kg bw/day
Based on:
test mat.

Overall reproductive toxicity

Reproductive effects observed:
not specified

Applicant's summary and conclusion